ReNetx Bio
Mr. Cassidy is the Chief Financial Officer of Arvinas. He has over 20 years of experience in the life sciences industry, including formerly serving as Chief Financial Officer of ReNetX Bio, Chief Financial Officer of CuraGen Corporation (NASDAQ: CRGN), a clinical stage biopharmaceutical company and Director and Controller of 454 Life Sciences Corporation, a life sciences company that developed and commercialized next generation DNA sequencing instruments and reagents.
This person is not in the org chart
This person is not in any offices
ReNetx Bio
1 followers
Changing lives through the REstoration of neural NETworks. ReNetx Bio's mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke, and glaucoma.